Home › NDC Lookup › Ingredients › Polyethylene Glycol And Propylene Glycol › 70000-0088-01
Dry eye relief polyethylene glycol and propylene 400 4 mg/mL; 3 mg/mL Gel, 10 mL — NDC 70000-0088-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Dry eye relief polyethylene glycol and propylene 400 4 mg/mL; 3 mg/mL Gel, 10 mL — NDC 70000-0088-1 (Billing 70000-0088-01)

by CARDINAL HEALTH 110, LLC. DBA LEADER · 10 mL in 1 BOTTLE, DROPPER

This is a package of 10 mL of Dry eye relief polyethylene glycol and propylene 400 4 mg/mL; 3 mg/mL Gel from CARDINAL HEALTH 110, LLC. DBA LEADER, marketed since Mar 2021 and currently FDA-listed, this package's marketing is listed to end Nov 2026; retail pharmacies pay about $0.6476 per mL (NADAC). It is this product's only package size.

NDC 70000-0088-01
🏷️ FDA NDC (as labeled) 70000-0088-1 billing pads the package segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 70000-0088-1 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
70000 labeler · 0088 product · 1 package
Package marketed since
Mar 9, 2021
Package marketing ended
Nov 30, 2026
Sample package
No — commercial package
Billing quantity
10 mL per package
Barcode (UPC-A, from the NDC)
3 7000000881 9
FDA record last changed
Jul 24, 2026
🚨
Active recall for this product.
Class I · Nov 13, 2023 — Non-Sterility (Kilitch Healthcare India Limited) · FDA recall D-0295-2024
Lots / codes: All lots · reported Feb 14, 2024
Class I · Oct 31, 2023 — Non-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility. (Cardinal Health Inc.) · FDA recall D-0135-2024
Lots / codes: ALL LOTS · reported Nov 29, 2023
Check your lot/expiration against the official notice — look up the recall number in the FDA recall database ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 70000-0088-1
Product NDC 70000-0088
11-digit billing NDC 70000008801
NCPDP billing unit ML — per mL (volume)
RxCUI 895753
UNII B697894SGQ, 6DC9Q167V3
Application # M018
SPL Set ID f8da3af5-9172-4023-be82-0fd5bd891616
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2021-03-09
Marketing end 2026-11-30
Route OPHTHALMIC
Dosage form GEL
Substance POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 86209902484020
GPI class Dry Eye Relief
GCN Seq No 067277
GCN 29804
HICL code 025225
Ingredient (HICL) Propylene Glycol/Peg 400
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q6
Therapeutic class — intermediate (HIC2) Ophthalmic Preparations
HIC3 code Q6T
Therapeutic class — specific (HIC3) Artificial Tears
AHFS code 52:92.00.00
AHFS class Eent Drugs, Miscellaneous
FDB label name DRY EYE RELIEF 0.3-0.4% DROP
FDB brand name Dry Eye Relief
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 067277
  • GCN: 29804
  • GPI-14 (Medi-Span): 86209902484020
  • HICL (First Databank): 025225
  • AHFS class code: 52:92.00.00
  • RxCUI (RxNorm): 895753
Why two NDCs? The FDA registers this code as 70000-0088-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 70000-0088-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

Label name DRY EYE RELIEF 0.3-0.4% DROP Ingredient Propylene Glycol/Peg 400
🧪 What is this product?

This is an over-the-counter ophthalmic gel containing polyethylene glycol 400 and propylene glycol, which are lubricants commonly used to relieve dry eye discomfort. Both ingredients function as humectants that help retain moisture on the eye surface and provide a protective film. This product is marketed under the FDA's over-the-counter monograph rules for eye lubricants rather than as an individually approved application.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly $0.648 $6.48 / 10 ml
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per mL) — tap or hover for the price & month
May 2022 Oct 2022 $0.653 $0.648
▼ Down 1% over the last 2 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
70000-0088-01 You're viewing this Main listing 10 mL in 1 BOTTLE, DROPPER 2021-03-09 Nov 30, 2026 Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Dry eye relief 400 4 mg/mL; 3 mg/mLthis 70000-0088-01 CARDINAL 10 ml $0.648 — FDA listed —
GenTeal Tears Gel Drops 400 4 mg/mL; 3 mg/mL 00065-8067-01 Alcon 8 ml $1.090 — Availability likely +68%
Systane 400 4 mg/mL; 3 mg/mL 00065-0454-07 Alcon 10 ml $1.130 — Availability likely +75%
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2021
On the market since
Mar 2021
📍
2026
Currently FDA-listed
5 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII R57ZHV85D4
    Boric acid is a weak acid derived from boron. In medicines, it typically serves as a buffer to help maintain the product's pH level and may act as a preservative in certain formulations.
  • UNII M4I0D6VV5M
    Calcium chloride is a salt compound that acts as a firming agent and source of calcium ions in medications. It's used in formulations to help maintain tablet structure, improve texture, or serve as a buffering agent.
  • UNII 7FLD91C86K
    Edetate disodium is a chemical compound that binds and removes certain metal ions. In medicines, it acts as a preservative and stabilizer by preventing metals like calcium from interfering with the product's shelf life and consistency.
  • UNII 3NXW29V3WO
    Hypromellose is a plant-based thickener made from cellulose. It's used in medicines as a binder to hold ingredients together, a coating for tablets, and a thickener for liquids.
  • UNII 02F3473H9O
    A mineral salt used in medications as a source of magnesium. It helps bind ingredients together, improve texture, and maintain the product's stability during storage.
  • UNII 660YQ98I10
    Potassium chloride is a mineral salt used in medicines as a buffer and to help maintain the proper pH balance and stability of the formulation during storage and use.
  • UNII 91MBZ8H3QO
    Sodium borate is an inorganic salt compound used in medicines as a buffer to help maintain a stable pH level, and sometimes as a mild preservative or cleansing agent in topical formulations.
  • UNII 451W47IQ8X
    Sodium chloride is common table salt. It's used in medicines as a buffer to maintain proper pH, as a filler to add bulk, or to adjust the osmotic balance in liquid formulations.
  • UNII G538EBV4VF
    Sodium chlorite is a white crystalline salt used as a preservative and antimicrobial agent in medications. It helps prevent bacterial and fungal growth to maintain product stability during storage.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.
  • UNII 86Q357L16B
    Zinc chloride is a mineral salt used as a buffer and pH regulator in medications. It helps maintain the chemical stability and proper acidity level of the drug formulation.

11 inactive ingredients listed in the exact product block matched to this NDC.

The official label also states boric acid, edetate disodium, potassium chloride, mangnesium chloride, sodium chloride, sodium borate, purified water.  May contain hydrochloric acid and/or sodium hydroxide to adjust pH.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerCARDINAL HEALTH 110, LLC. DBA LEADER
FDA applicationM018 (OTC MONOGRAPH DRUG)
Labeler code70000
First marketedMar 2021
Product typeHuman Otc Drug
Portfolio163 products on file

More NDCs from CARDINAL HEALTH 110, LLC. DBA LEADER labeler code 70000

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 📄 Keep Out of Reach of Children 📄 Other Information 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 32 words ▾

Uses ▪ for the temporary relief of burning and irritation due to dryness of the eye ▪ for use as a protectant against further irritation or to relieve dryness of the eye

⏱️ Dosage and Administration 18 words ▾

Directions ▪ shake well before using ▪ put 1 or 2 drops in the affected eye(s) as needed

⚠️ Warnings 5 words ▾

Warnings For external use only

🧪 Active Ingredient 12 words ▾

Active Ingredients Purpose Polyethylene Glycol 400 0.4% Lubricant Propylene Glycol 0.3% Lubricant

🧪 Inactive Ingredients 29 words ▾

Inactive ingredients boric acid, edetate disodium , potassium chloride, mangnesium chloride , sodium chloride, sodium borate , purified water. May contain hydrochloric acid and/or sodium hydroxide to adjust pH.

🎯 Purpose 12 words ▾

Active Ingredients Purpose Polyethylene Glycol 400 0.4% Lubricant Propylene Glycol 0.3% Lubricant

📄 Do Not Use 23 words ▾

Do not use ▪ if this product changes color or becomes cloudy ▪ if you are sensitive to any ingredient in this product

📄 When Using This Product 23 words ▾

When using this product ▪ do not touch tip of container to any surface to avoid contamination ▪ replace cap after each use

📄 Stop Use and Ask a Doctor If 40 words ▾

Stop use and ask a doctor if you experience any of the following: ▪ you feel eye pain ▪ changes in vision ▪ continued redness or irritation of the eye ▪ condition worsens or persists for more than 72 hours

📄 Keep Out of Reach of Children 19 words ▾

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

📄 Other Information 7 words ▾

Other information ▪ store at room temperature

📄 Package Label / Principal Display Panel 76 words ▾

Principal Display Panel LEADER® NDC 70000-0088-1 Sterile Dry Eye Relief Polyethylene Glycol 400, 0.4% Propylene Glycol, 0.3% Lubricant

0.33FL OZ (10 mL) 0.4% / 0.3% bottle label

Principal Display Panel LEADER® NDC 70000-0088-1 Sterile Dry Eye Relief Polyethylene Glycol 400, 0.4% Propylene Glycol, 0.3% Lubricant Moisturizes Dry Eyes Actual Bottle Size on Side Panel COMPARE TO SYSTANE® LUBRICANT GEL DROPS active ingredients* 100% Money Back Guarantee

0.33FL OZ (10 mL) 0.4% / 0.3% carton

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
← 70000-0087-01 · CARDINAL 70000-0089-01 · CARDINAL →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.